Robert Maki, MD, PhD

Dr. Robert Maki is Professor of Medicine, Pediatrics, and Orthopaedics, and the Steven Ravitch Chair in Pediatric Hematology-Onocology. He has published more than 100 articles on sarcoma treatment and basic science research, having worked on studies related to sarcoma since 1985. He treats adults and children with sarcomas (connective tissue cancers of bone, cartilage, muscle, fat and other soft tissue) and has an interest in translational research and the biology that leads to different types of sarcomas.

After his MD/PhD at Cornell Medical College in New York City, he was a resident at Brigham and Women’s Hospital in Boston before a medical oncology fellowship at Dana-Farber, and was on staff at Dana-Farber before starting at Memorial Sloan-Kettering in 1999. In March, 2011 he moved to the Mount Sinai Medical Center to develop the effort in adult sarcoma therapy and research.

Dr. Maki’s efforts at Mount Sinai will be directed towards an increasingly integrative effort sarcoma biology and treatment of sarcomas. His group will conduct clinical trials in adults with sarcomas, and they will also conduct translational studies in sarcoma biology to identify the next possible targets for new drugs to treat sarcomas.

Dr Maki now also leads the Pediatric Hematology-Oncology program at Mount Sinai, and will continue his personal interest in the care of adolescents with sarcomas, while also expanding the role of the pediatric hematology-oncology program in the treatment and research of pediatric cancers such as acute lymphoblastic leukemia, as well as “benign” but often life-threatening hematologic conditions.